This Article Full Text Full Text (PDF) All Versions of this Article: 35/6/1466    most recent 01.STR.0000127425.47266.20v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sasaki, T. Articles by Inoue, I. Search for Related Content PubMed PubMed Citation Articles by Sasaki, T. Articles by Inoue, I. Related Collections Cell signalling/signal transduction Gene expression Gene regulation Growth factors/cytokines Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage

(Stroke. 2004;35:1466.)
© 2004 American Heart Association, Inc.

Original Contributions

Role of p38 Mitogen-Activated Protein Kinase on Cerebral Vasospasm After Subarachnoid Hemorrhage

Toshiyuki Sasaki, MD; Hidetoshi Kasuya, MD; Hideaki Onda, MD; Atsushi Sasahara, MD; Shin Goto, MD; Tomokatsu Hori, MD Ituro Inoue, MD

From the Department of Neurosurgery, Tokyo Women’s Medical University, Tokyo; and the Division of Genetic Diagnosis, Tokyo University, Tokyo, Japan.

Correspondence to Hidetoshi Kasuya, MD, Department of Neurosurgery, Tokyo Women’s Medical University, Kawada-cho 8-1, Shinjuku-ku, Tokyo 162-8666, Japan. E-mail hkasuya{at}nij.twmu.ac.jp

Background and Purpose— Inflammatory cytokines are involved in the pathogenesis of cerebral vasospasm after subarachnoid hemorrhage (SAH). This study was conducted to examine the role of p38 mitogen-activated protein kinase (MAPK) in the development of vasospasm and cytokine production.

Methods— We measured the expression levels of genes and proteins related to inflammation in human vascular smooth muscle cells (hVSMCs) treated with hemolysate and FR167653 (FR) (1µmol/L), a selective p38MAPK inhibitor, for 48 hours by TaqMan real-time reverse transcription-polymerase chain reaction (RT-PCR) and ELISA. Twenty-one dogs were assigned to 3 groups of 7 animals: control, placebo, and FR-treated (1 mg/kg/d) groups in a double-hemorrhage model. The effects were assessed through the caliber of the basilar artery, and the changes in gene expressions and the activation of p38MAPK were assessed by Western blot analysis.

Results— Treatment of hVSMCs with hemolysate induced significant upregulation of interleukin (IL)-1, IL-1ß, and IL-8 gene and protein expressions, which was suppressed significantly with FR. The mean vessel caliber on day 7, as a percentage of that of day 0, was 49% in the placebo, and 74% in the FR group (P=0.0001). The gene expression levels of IL-1, IL-1ß, and IL-8 in the arterial wall were extremely elevated in the placebo, and significantly suppressed in the FR group (P=0.0027, 0.0002, and 0.0073). p38MAPK phosphorylation was stimulated in the placebo and hemolysate in vitro, and suppressed in the FR group.

Conclusions— These results suggest that p38MAPK is activated in the arterial wall after SAH, leading to the development of vasospasm, possibly through the upregulation of inflammatory cytokines.

Key Words: cytokines • inflammation • mitogen-activated protein kinase kinases • subarachnoid hemorrhage • vasospasm, intracranial

This article has been cited by other articles:

				E. Laaksamo, R. Tulamo, M. Baumann, R. Dashti, J. Hernesniemi, S. Juvela, M. Niemela, and A. Laakso Involvement of Mitogen-Activated Protein Kinase Signaling in Growth and Rupture of Human Intracranial Aneurysms Stroke, March 1, 2008; 39(3): 886 - 892. [Abstract] [Full Text] [PDF]

				H. Yatsushige, M. Yamaguchi, C. Zhou, J. W. Calvert, and J. H. Zhang Role of c-Jun N-Terminal Kinase in Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage Stroke, July 1, 2005; 36(7): 1538 - 1543. [Abstract] [Full Text] [PDF]